Product Information

PRAMIPEXOLE ER 3 MG TABLET is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $1.5278 per EA under NDC 55111061430. Its NADAC has been published 244 times since Oct 19, 2016.

FDA first approved this application on Aug 7, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PRAMIPEXOLE ER 3 MG TABLET

Pramipexole dihydrochloride
$1.5278per EA

Strength

3 mg/1

NDC

55111061430

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

PRAMIPEXOLE DIHYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA203354

FDA Approved

8/7/2015

TE Code

AB

On Market Since

8/14/2015

Pharmacological Classes

Dopamine Agonists
Nonergot Dopamine Agonist

Price Statistics

The NADAC for PRAMIPEXOLE ER 3 MG TABLET has been published 244 times since Oct 19, 2016, and over the history we have for it it has declined 87.2%. The table below summarizes its recorded NADAC range and movement.

Current price$1.5278 per EA
All-time high$11.9371 (Nov 15, 2017)
All-time low$1.4794 (Sep 23, 2026)
52-week high$3.2366
52-week low$1.4794
Median price$5.3371
Average price$6.5033
Largest weekly change-34.5% (Apr 22, 2020)
Weeks tracked244
Tracking sinceOct 19, 2016

Price History

1W

0.0%

1M

+3.3%

3M

-14.9%

6M

-42.4%

1Y

-53.1%

3Y

-80.5%

5Y

-80.5%

All

-87.2%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PRAMIPEXOLE ER 3 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PRAMIPEXOLE ER 3 MG TABLET, manufactured by Dr. Reddy's Laboratories Inc., is $1.5278 per EA (NDC 55111061430), effective Nov 11, 2026.

How has the price of PRAMIPEXOLE ER 3 MG TABLET changed over time?

Over the history we have for it, the NADAC for PRAMIPEXOLE ER 3 MG TABLET has declined 87.2%. It has been tracked across 244 weekly CMS publications since Oct 19, 2016.

What are the highest and lowest recorded NADAC prices for PRAMIPEXOLE ER 3 MG TABLET?

Since Oct 19, 2016, the NADAC for PRAMIPEXOLE ER 3 MG TABLET has ranged from a low of $1.4794 (Sep 23, 2026) to a high of $11.9371 (Nov 15, 2017), with a median of $5.3371 per EA.

Are there cheaper alternatives to PRAMIPEXOLE ER 3 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as PRAMIPEXOLE ER 3 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures PRAMIPEXOLE ER 3 MG TABLET?

PRAMIPEXOLE ER 3 MG TABLET (NDC 55111061430) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.